Pharmaceuticals

Global Drug Discovery Market Report 2026–2030: Data-Driven Growth Insights

February 13, 2026February 13, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the drug discovery market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Drug Discovery Market show for the 2026–2030 period?

The drug discovery market has experienced substantial expansion recently. Its valuation is projected to increase from $124.11 billion in 2025 to $142.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. Factors contributing to its historical growth include an uptick in chronic and infectious diseases, progress in molecular biology techniques, increased research and development expenditure by pharmaceutical firms, an expansion in biotechnology partnerships, and the provision of research funding.

The drug discovery market is projected to undergo substantial growth in the upcoming years. Its valuation is expected to reach $250.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This projected expansion is driven by the emergence of AI-driven drug discovery platforms, the broadening scope of personalized medicine, the integration of omics data in drug design, the increase in biopharmaceutical outsourcing activities, and the implementation of automation and robotics within laboratories. Noteworthy trends anticipated during this period include advancements in high-throughput screening, the progression of targeted drug development, the adoption of personalized medicine approaches, the incorporation of pharmacogenomics, and nanotechnology-enabled drug discovery methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Drivers Are Shaping The Development Of The Drug Discovery Market?

The drug discovery market is anticipated to expand due to increasing healthcare expenditure. Countries across the globe allocate a substantial portion of their GDP to healthcare costs, covering hospital care, physician and clinical services, other professional services, dental services, other health, residential, and personal care, home health care, nursing care facilities, and continuing care retirement communities, alongside prescription drugs, among other categories. Drug discovery constitutes a crucial element of health expenditure, as it is essential for treating diseases and prolonging life. There is a growing demand for novel medications to address emerging diseases. For instance, in October 2024, according to the Centers for Medicare and Medicaid Services, a US-based federal agency, national health expenditure increased 4.1% to $4.5 trillion in 2022, or $13,493 per person. Over the period of 2023–32, the average national health expenditure growth (5.6%) is projected to surpass that of average GDP growth (4.3%), leading to an increase in the health spending share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Therefore, the escalation in healthcare expenditures is fueling the growth of the drug discovery market.

Which Segments Are Contributing To The Growth Of The Drug Discovery Market?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

What Trends Are Reshaping The Dynamics Of The Drug Discovery Market?

Major companies operating in the drug discovery market are implementing various new technologies, including AI and imaging, to decrease the time required for drug development. Imaging technology specifically allows for the non-invasive visualization, characterization, and quantification of biological activities occurring within organisms in response to medications. These methods, which harness the strengths of either probes or the tissue itself, are crucial for gaining insights into diseases and identifying new therapeutic approaches. For instance, in May 2023, Google Cloud launched two new AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, with the goal of accelerating drug discovery and precision medicine. These tools are designed to assist biotech and pharmaceutical companies in advancing drug discovery and precision medicine efforts. The Target and Lead Identification Suite helps in identifying the function of amino acids and proteins, while the Multiomics Suite speeds up the discovery and interpretation of genomic data, thereby aiding in the design of precision treatments.

Who Are The Primary Competitors In The Global Drug Discovery Market?

Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Discovery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795